Navigation Links
Announcing ValGenesis On-Demand SaaS Solution
Date:3/24/2011

FREMONT, Calif., March 24, 2011 /PRNewswire/ -- ValGenesis, Inc., an industry-leading provider of Validation Lifecycle Management (VLM) software solutions, today announced the availability of its industry-proven solution as an On-Demand software as a service (SaaS) offering hosted on MUSA's Validated Cloud.

ValGenesis On-Demand provides an enterprise-level, secure Validation Lifecycle Management solution accessible via the Internet through MUSA's Validated Cloud on a pay-as-you-go basis with options for monthly, quarterly or annual payments. The On-Demand instance of ValGenesis includes: Validation Lifecycle Management, SOP management, asset management, scheduler for the periodic review process, change control process, document management, requirements management, risk assessment and electronic batch records (EBR).

Key Benefits of ValGenesis On-Demand:

  • ValGenesis On-Demand hosted on MUSA's Validated Cloud can be implemented in only two weeks
  • IQ, OQ, and PQ documentation for hardware and software is ready for audits
  • Delivered through Secure Socket Layer (SSL) access or Virtual Private Network (VPN)
  • Available to North American and European clients
  • Optional Technical and Quality Support for ValGenesis and MUSA's Validated Cloud
  • Free, automatic and transparent upgrades providing new features and documentation

"We've entered into a strategic business alliance with MUSA to provide our clients with the same ValGenesis experience and solutions in the cloud," explained Dr. Siva Samy, Chief Product Strategist at ValGenesis, Inc. "ValGenesis On-Demand and Validated Cloud are both 21 CFR Part 11 compliant, pre-documented and audited in accordance with global governmental regulations, allowing us to deliver a fully validated solution at a lower cost and in only two weeks to produce a more immediate return on investment."

Douglas Lantigua, Principal of MUSA Technology Partners, commented: "ValGenesis' commitment to validation and regulatory compliance is outstanding and we're pleased that they've chosen to deploy their flagship Software as a Service (SaaS) offering on our Validated Cloud. ValGenesis, the world-class provider of Validation Lifecycle Management, coupled with the industry-leading MUSA Validated Cloud, provides the first automatic and paperless validation solution in the cloud, yielding a perfect blend of our combined expertise. Our successful partnership and implementation of ValGenesis is the ideal model for future SaaS deployments in the cloud, and together we're excited for our continued success at bringing new clients into the On-Demand version of ValGenesis."

ValGenesis On-Demand eliminates the need for paper-based validation systems and their associated redundancies and inefficiencies. The On-Demand instance of ValGenesis can be deployed for use in a single department at a single location or for multi-site companies to enforce validation policies and to globalize and standardize the validation process across all sites. The net result provides 100% paperless and automated electronic validation, which significantly reduces validation costs and validation cycle times while improving consistency and efficiency.

About ValGenesis:

ValGenesis is an innovative software platform designed to provide the foundation for compliance-based validation activities in Life Science companies. ValGenesis is the first Enterprise application to automate the corporate validation lifecycle and to track the Validation Inventory. Through an industry peer review committee, the Parenteral Drug Association (PDA) recognized ValGenesis by awarding the very prestigious New Innovative Technology award for the year 2005. ValGenesis is designed to be fully compliant with U.S. FDA 21 CFR Part 11 compliance requirements. For more information, visit the ValGenesis website at http://www.valgenesis.com.

About MUSA Technology Partners:

MUSA is a rapidly growing consulting firm that excels in innovative solutions and support for firms in the Life Sciences industry. Their compliance, validation and technology engineers have years of experience working with firms ranging from enterprise-sized, multi-national companies to start-ups in the biotechnology, pharmaceutical and health care industries. MUSA's focus on the Life Sciences industry differentiates them from other cloud services because they understand the Life Sciences business and its compliance requirements. MUSA's service offerings include FDA, GxP and Quality System compliance assessment and evaluation, Validation as a Service™ (VaaS™), disaster recovery and data protection for business continuance, lab services and more. For more details on MUSA Technology Partners, please navigate to http://www.musatechnology.com or http://www.validatedcloud.com.

Contact:

Mike Beaudro, Marketing Manager
ValGenesis, Inc.
510-445-0505
mike.beaudro@valgenesis.com
http://www.valgenesis.com

Duncan Berkeley, Product Manager
MUSA Technology Partners LLC
800-401-9123 x716
dberkeley@musatechnology.com  
http://www.musatechnology.com  
http://www.validatedcloud.com

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE ValGenesis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Announcing Sustainability in Packaging 2010: Strategies to make sustainability sustainable
2. Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010
3. Regado Biosciences, Inc. Continues to Expand Its Patent Portfolio By Announcing Issuance of a New Patent for Its Product Candidates, the REG1 and REG2 Anticoagulation Systems
4. ValGenesis, Inc. Announces Integration of ValGenesis Solution with Microsoft SharePoint Server
5. ValGenesis, Inc., the Leading Provider of Validation Lifecycle Management Solutions to Regulated Life Science Companies, Today Announced Support for EMC Documentum v.6.5
6. Cepheid Receives FDA Clearance for First Rapid On-Demand Molecular Diagnostic Test for MRSA and S. aureus
7. Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures
8. ParagonRx Sponsors Webinar-on-Demand By DSEC on Role of Drug Safety Officers
9. Reaction Progress Kinetic Analysis to Study Organic Reactions: Free On-Demand Online Seminar
10. PerkinElmer Expertise and Solutions Integral to Food Safety Monitoring for the Beijing Games : Methods, Applications Expertise and Instrumentation Deployed in Mobile Laboratory
11. StollerUSA Launches Bio-Forge.com to Offer Solutions for Crops Under Stress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... 11, 2016 , ... Global Stem Cells Group, ... Global Stem Cells Network (GSCN) to distribute exosome injection and other biological products ... Costa Rica, Dominican Republic, Colombia, Argentina, Nicaragua, Panama, El Salvador, Venezuela, Peru, Ecuador, ...
(Date:2/10/2016)... Feb. 10, 2016 NX Prenatal Inc., a ... NeXosome® technology for early warning of adverse pregnancy ... recent study by Dr. Thomas McElrath ... Maternal Fetal Medicine,s (SMFM) annual meeting held in ... , 2016.  The presentation reported initial positive top-line ...
(Date:2/10/2016)... , Feb. 10, 2016  Matchbook, Inc., a ... fast growing biotech companies, announced today the appointment ... Strategic Advisor. Jim brings nearly 25 years of ... procurement, having spent nearly two decades in executive ... and Procurement at Genzyme and, most recently headed ...
(Date:2/10/2016)... CA (PRWEB) , ... February 10, 2016 , ... ... Multiplex Testing (PROMPT), a research registry built on the secure online PatientCrossroads platform, ... 2014. More than 1,600 participants have joined the PROMPT study, which seeks to ...
Breaking Biology Technology:
(Date:1/25/2016)...   Unisys Corporation (NYSE: UIS ) today announced ... International Airport, New York City , to help ... to enter the United States using passports ... pilot testing of the system at Dulles last year. The ... during January 2016. --> pilot testing of the ...
(Date:1/20/2016)... A market that just keeps on growing. Molecular Diagnostics ... genomics knowledge. Learn all about it in this new ... trends are pushing market growth and company valuations. Trends ... pathogen evolution - next generation sequencing - emergence of ... the role of genetic material in Disease and Health ...
(Date:1/13/2016)... , January 13, 2016 ... has published a new market report titled - Biometric Sensors ... and Forecast, 2015 - 2023. According to the report, the global ... and is anticipated to reach US$1,625.8 mn by 2023, ... 2023. In terms of volume, the biometric sensors market ...
Breaking Biology News(10 mins):